More flexibility in early-phase development for cell therapies is needed, a panel of US Food and Drug Administration (FDA) ...

As clinical development becomes increasingly complex and costly, biotech and pharmaceutical companies are rethinking how they partner with contract research organizations (CROs) to harmonize speed, ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Options abound for hospitals looking to capitalize on these new data transfer technologies, but so do potential pitfalls. For ...

Outsourcing of non-core services and resources is common practice in today’s world as companies look to reduce overhead and costs and streamline their businesses. Pharmaceutical companies outsource ...

Also Announces Marketing Program VANCOUVER, BC / ACCESS Newswire / June 2, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H) (WKN: A3EKSZ) ("Onco" or the "Company") announces, ...

TEMPE, Ariz.--(BUSINESS WIRE)--Addressing some of the most time-consuming challenges of biopharma companies in building clinical studies and rolling out drug trials, Anju Software has launched ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

Gene and cell therapy have moved from the realm of science fiction to medical reality. These new therapies have the potential to permanently correct genetic disorders with a single administration. But ...